Ovarian Cancer GOG 187

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy.

Subscribe to Our Newsletters

Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209
Reply STOP to cancel, HELP for help. Message and data rates may apply. See terms and privacy here.

Hartford HealthCare Offices

100 Pearl Street, Hartford, CT 06103 • Contact Us

Donations to Hartford HealthCare are managed by the Hartford Hospital Department of Philanthropy, a Connecticut tax-exempt organization under section 501(c)(3) of the IRS code (E.I.N. 06-0646668). For more information, click here.

Interpretive Services

Community Health Needs Assessment
Financial Assistance
Non-Discrimination
Patient Rights/Privacy
Public Notices
Website Terms/Conditions
Website Privacy Policy

Ovarian Cancer GOG 187

Connect With Us

Subscribe to Our Newsletters

Hartford HealthCare Offices